Quantum eMotion Inc
QNC
Blue Horizon Global Capital Corp
BHCC
RAMM Pharma Corp
RAMM
Petrichor Energy Inc
PTP.H
Minaean SP Construction Corp
MSP
CA Stock MarketDetailed Quotes
XRX XORTX Therapeutics Inc
- 4.800
- 0.0000.00%
15min DelayMarket Closed Nov 4 16:00 ET
59.00MMarket Cap-13.64P/E (TTM)
0.000High0.000Low0Volume0.000Open4.800Pre Close0.00Turnover5.15052wk High0.00%Turnover Ratio12.29MShares3.18052wk Low-0.352EPS TTM52.74MFloat Cap9.979Historical HighLossP/E (Static)10.99MShs Float0.352Historical Low-0.235EPS LYR0.00%Amplitude--Dividend TTM17.78P/B1Lot Size--Div YieldTTM
XORTX Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 133.34%865.45K | 360.17%770.45K | 129.79%1.3M | 130.68%380.34K | 186.72%381.84K | 164.45%370.89K | 0.00%167.43K | -51.09%565.97K | 20.71%164.88K | -54.70%133.18K |
| Selling and administrative expenses | 136.21%834.65K | 370.40%752.42K | 116.94%1.1M | 107.24%328.14K | 110.83%256.65K | 194.32%353.35K | 0.00%159.96K | -36.38%506.17K | 42.01%158.34K | -19.48%121.74K |
| -General and administrative expense | 136.21%834.65K | 370.40%752.42K | 116.94%1.1M | 107.24%328.14K | 110.83%256.65K | 194.32%353.35K | 0.00%159.96K | -36.38%506.17K | 42.01%158.34K | -19.48%121.74K |
| Research and development costs | 112.20%26.42K | 469.20%13.79K | 595.43%277.46K | 9,204.70%142.55K | 1,765.60%120.03K | -18.27%12.45K | 0.00%2.42K | -88.34%39.9K | -92.41%1.53K | -95.34%6.43K |
| Depreciation amortization depletion | -14.17%4.37K | -15.96%4.24K | 2.71%20.44K | 2.62%5.14K | 2.92%5.15K | 2.70%5.1K | 0.00%5.05K | 3.02%19.9K | 1.77%5.01K | 2.77%5.01K |
| -Depreciation and amortization | -14.17%4.37K | -15.96%4.24K | 2.71%20.44K | 2.62%5.14K | 2.92%5.15K | 2.70%5.1K | 0.00%5.05K | 3.02%19.9K | 1.77%5.01K | 2.77%5.01K |
| Other operating expenses | ---- | ---- | ---95.49K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -133.34%-865.45K | -360.17%-770.45K | -129.79%-1.3M | -130.68%-380.34K | -186.72%-381.84K | -164.45%-370.89K | 0.00%-167.43K | 51.09%-565.97K | -20.71%-164.88K | 54.70%-133.18K |
| Net non-operating interest income (expenses) | 77.46%-665 | 78.87%-1.88K | 63.69%-13.51K | 94.36%-815 | 84.00%-839 | 69.01%-2.95K | 0.00%-8.91K | -66.89%-37.21K | -95.08%-14.46K | -43.35%-5.25K |
| Non-operating interest expense | -77.46%665 | -78.87%1.88K | -63.69%13.51K | -94.36%815 | -84.00%839 | -69.01%2.95K | 0.00%8.91K | 66.89%37.21K | 95.08%14.46K | 43.35%5.25K |
| Other net income (expenses) | 605,193.46%647.66K | -1,079.09%-1.4M | 211.43%29.41K | -606.77%-71.57K | -742.87%-42.23K | 101.89%107 | 0.00%143.1K | 98.98%-26.4K | -193.34%-10.13K | 171.46%6.57K |
| Gain on sale of security | 812.45%647.66K | -1,019.18%-1.32M | 111.22%2.96K | 30.81%-7.01K | -742.87%-42.23K | -1,508.69%-90.91K | 0.00%143.1K | -162.29%-26.4K | -137.43%-10.13K | 171.46%6.57K |
| Special income (charges) | --0 | ---- | --26.45K | ---64.56K | --0 | --91.01K | ---- | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --64.56K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---91.01K | --0 | ---- | ---91.01K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---85.73K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Net income continuous operations | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Diluted earnings per share | 80.16%-0.0233 | -4,073.48%-0.2348 | -100.00%-0.2348 | -0.1174 | -377.20%-0.1174 | -304.84%-0.1174 | 0.00%-0.0056 | 83.33%-0.1174 | 0 | 57.03%-0.0246 |
| Basic earnings per share | 80.16%-0.0233 | -4,073.48%-0.2348 | -100.00%-0.2348 | -0.1174 | -377.20%-0.1174 | -304.84%-0.1174 | 0.00%-0.0056 | 83.33%-0.1174 | 0 | 57.03%-0.0246 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.